|
INVESTIGATIVE UROLOGY
Urethral
dysfunction in diabetic rats
Torimoto K, Fraser MO, Hirao Y, De Groat WC, Chancellor MB, Yoshimura
N
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh,
Pennsylvania, USA
J Urol. 2004; 171: 1959-64
- Purpose:
We investigated the effects of diabetes mellitus (DM) on urethral relaxation
mechanisms during reflex bladder contractions in rats.
- Materials
and Methods: Five weeks after streptozotocin injection (65
mg/kg intraperitoneally) the effects of DM on urethral relaxation mechanisms
were evaluated by simultaneous recordings of intravesical pressure under
isovolumetric conditions and urethral perfusion pressure (UPP) using
urethane anesthesia.
-
Results:
In diabetic rats the UPP nadir during urethral relaxation and intravesical
pressure thresholds for inducing urethral relaxation were significantly
higher (199% and 92%, respectively) than in normal rats, while baseline
UPPs were not significantly different. The mean rate and amplitude of
high frequency oscillations of urethral striated muscle in diabetic
rats were also significantly lower (17% and 64%, respectively) compared
with normal rats. Following alpha-bungarotoxin treatment to eliminate
striated muscle sphincter contractions intravenous administration of
L-arginine (200 mg/kg intravesically), the substrate of nitric oxide
(NO) synthase, decreased the UPP nadir (36% and 22%, in diabetic and
normal rats) as well as intravesical pressure thresholds (49% and 22%,
respectively). The effect was greater (61% to 126%) in diabetic rats
than in normal rats. In each group of rats the effect of L-arginine
was inhibited by Nomega-nitro-L-arginine (100 mg/kg intravesically),
a NO synthase inhibitor.
- Conclusions:
During reflex bladder contractions streptozotocin induced diabetic rats
exhibited smooth and striated muscle dysfunctions of the urethral outlet.
L-arginine therapy, which could augment urethral smooth muscle relaxation
by increasing NO production, may be useful for partially restoring the
urethral relaxation mechanism in DM.
- Editorial
Comment
Cystopathy characterized by high post-void residual urine volume, weaken
bladder sensations and diminished bladder contractility affects around
80% of patients with noninsulin dependent diabetes mellitus. However,
as yet, little is known on the effects of diabetes mellitus on urethral
function.
Previous studies showed that nitric oxide is the most important transmitter
that induces urethral relaxation during voiding. It has also been demonstrated
that relaxation responses to nitric oxide in urethral muscle strips
were decreased in diabetic rabbits. Thus, the authors investigated if
urethral relaxation during the voiding reflex would be decreased in
diabetes mellitus. In addition, the authors evaluated the effects on
diabetes mellitus induced urethral dysfunction of L-arginine treatment,
a drug that can increase endogenous nitric oxide production.
The authors found that relaxation mechanisms of urethral striated and
smooth muscle during reflex bladder contractions are impaired in diabetes
mellitus. They proposed that this defect coupled with bladder hypoactivity
could result in inefficient voiding and bladder overdistention in diabetes
mellitus. The authors also proposed that therapy with L-arginine might
be useful for partially restoring the urethral relaxation mechanism
in diabetes mellitus.
Dr.
Francisco J.B. Sampaio
Full-Professor and Chair, Urogenital Research Unit
State University of Rio de Janeiro
Rio de Janeiro, Brazil
|